Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01268215Phase 2Unknown
Phase 2, randomised trial of budesonide in bronchopulmonary dysplasia (BPD) (3 arms), sponsored by East Carolina University. Primary endpoint: Development of Bronchopulmonary Dysplasia. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01268215.